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Introduction
In several studies, it was shown that humoral factors secreted by mechanically stressed cardiomyocytes activate a vast network of intra-and intercellular transduction signals that act in an autocrine or paracrine fashion. These factors are able to alter myocardial ultrastructure and determine cardiac fibroblast hypertrophy and/or apoptosis, mesenchymal fibrotic, inflammatory processes and can alter cardiac gene expression [1] [2] [3] [4] [5] . This series of events is the basis of myocardial remodeling [6] , which is a complex phenomenon of ultrastructural cardiac rearrangement. Because of the sensible changes in cardiomyocyte viability, energy metabolism and kinetic and electrical properties, as well as in cytoskeletal and extracellular matrix composition, myocardial remodeling is considered a key pathogenetic factor of chronic heart failure and of its natural history, which is marked by inexorable, progressive cardiac dysfunction [7] [8] [9] .
Cardiac hypertrophy is a fundamental process of adaptation to an increased workload due to hemodynamic overload [10] [11] [12] . Development of cardiac hypertrophy is a compensatory response because it augments the number of contractile units and reduces ventricular wall stress to normal levels in accordance with Laplace's Law. Prolonged myocardial hypertrophy triggered by chronic overload may damage the heart over time. Increased ventricular wall thickness initially reduces parietal stress, oxygen requirement and increases heart contractility. However, this compensatory effect is markedly curbed by subsequent expression of pro-apoptotic embryo-fetal genes and fibroblastic hyperplasia with increased collagen synthesis caused by the same biochemical mediators which determine hypertrophy. Loss of contractile tissue due to cardiomyocyte apoptosis and mesenchymal fibrosis is determined by increased collagen synthesis, causingthe heart to dilate and stiffen, which results in systolic and diastolic dysfunction [13] .
Beta-catenin has been implicated in cell-cell communication in a wide variety of developmental and physiological processes. Wnt/b-catenin signaling is required for different aspects of cardiac and vascular developments. Defective Wnt signaling can result in various cardiac and vascular abnormalities. In the adult heart and blood vessels, activity of the signaling pathway is quite low under normal conditions. However, it is reactivated during pathological cardiac remodeling induced by pressure overload to injured arteries and after myocardial infarction [14] .
In recent years, b-catenin signaling has been clearly shown to be involved in hypertrophic growth [15] . In contrast, little is known regarding Wnt/frizzled pathway in cardiomyocyte apoptosis. In other mammalian cell types, overexpression of b-catenin promotes apoptosis [16] [17] [18] . In a previous study, it was demonstrated that b-catenin was increased in cardiomyocytes of spontaneously hypertensive heart failure in rats compared with an age-matched control group [19] . In another study, it was indicated that when heart injury occurs, Wnt signaling activates and induces cardiac fibrosis [20] . Moreover, transfection with b-catenin-specific small interfering RNA or expression of dominant-negative T cell factor inhibited apoptosis, whereas expression of dominant stable b-catenin caused significant apoptosis in human ovarian surface epithelial cells [21] . Similar results were also obtained in human T/C28a cell line [22] , indicating pro-apoptotic roles for b-catenin and T cell factor.
Wnt/frizzled pathway is known to be involved in fibrosis of several organ systems (lungs, kidneys and liver) [23] [24] [25] [26] . WNT1 and WNT10B are upregulated in pulmonary fibrosis and in liver cirrhosis [23] . In cardiomyocytes, cardiac fibroblasts are regulated in vitro by Wnt signaling cascade [27] . Specific combinations of Wnt ligands and frizzled elicit distinct responses. In vivo, pediatric heart allographs with diastolic dysfunction and severe epicardial fibrosis display nuclear b-catenin accumulation in fibroblasts, suggesting activation of Wnt signaling [28] .
The present study aims to investigate the role of b-catenin in apoptosis, fibrosis and survival in cardiomyocytes.
Methods

Human cardiovascular tissue microarray
Tissue microarray used in this study was purchased from Provitro (Berlin, Germany) comprises heart specimens of normal tissue (n = 10) and myocardial scar tissue (n = 10). These tissues were collected from females and males with an age range of 25-84 years old. Infarct locations included anterior, posterior and septal segments. Normal tissues included both left and right ventricles. Only the former was used for analysis.
The study procedures conformed to the ethical guidelines of the 1975 Declaration of Helsinki and were reviewed and approved by the Institutional Review Board of the Armed Force Taichung General Hospital, Taichung and the China Medical University, Taichung, Republic of China. Verbal and written informed consents for inclusion in the study were obtained prior to sample collection.
Diabetic rat model
Male Wistar rats of 6 weeks old were obtained from the National Laboratory Animal Center, Taiwan. Ambient temperature was maintained at 25°C and the animals were kept on an artificial 12-h lightdark cycle. The rats were provided with standard laboratory chow (PMI Nutrition International Inc., Brentwood, MO, USA) and water ad libitum.
Streptozotocin (STZ) was previously shown to induce diabetes in rats [29] [30] [31] [32] ; therefore, it was administered in the animal model. All animals were acclimatized to the lab conditions for 1 week after their arrival prior to the experiment. All rats were randomly assigned into two groups, i.e., control group and STZ group. STZ group were injected with intraperitoneal injection of STZ (65 mg/kg body weight in citrate buffer [pH 4.5]), and control ones were injected with an equal volume of vehicle. Rats which were considered diabetic displayed fasting glucose levels at > 11.1 mM or > 200 mg/dL at 48 h after STZ injection, these were detected with AccuSoft test strips (Roche Diagnostics GmbH, Mannheim, Germany).
Immunohistochemistry
Tissue biopsies from human patients described in the Human Cardiovascular Tissue Microarray section were gathered and fixed with 10% buffered formalin for 1 overnight, embedded in paraffin and sectioned to 4 μm-thick fractions. The tissue biopsy samples were dried at 58°C overnight and then dewaxed in xylene for 40 min and rehydrated using graded series of ethanol solutions. Endogenous peroxidase activity was blocked by incubating in hydrogen peroxide blocking buffer (3% H 2 O 2 ) for 13 min. After the samples were rinsed in tap water for 15 min, the microarray biopsies were microwavetreated with pre-warmed citrate buffer (0.01M citric acid [pH 6.0]) for 15 min and then cooled down to room temperature (RT) for 30 min. Nonspecific binding was blocked with 5% cosmic calf serum (CCS; HyClone Laboratories Inc., South Logan, UT, USA) for 1 h and then incubated with primary antibody directed against b-catenin (1:100 dilution; Santa Cruz Biotechnology Inc., TX, USA) at RT for 1 overnight. Then, the samples were incubated with anti-mouse horseradish peroxidase (HRP) secondary antibody (1:100 dilution; Santa Cruz Biotechnology Inc., Dallas, TX, USA) at RT for 1 h. Immunoreactivity was visualized following incubation with 3,3'-diaminobenzidine (DAB) substrate (Roche Diagnostics GmbH, Mannheim, Germany) for 5 min. After the samples were washed with 1 × phosphate-buffered saline (1 × PBS; GIBCO, Auckland, New Zealand) for 10 min, the microarray was observed under a microscope (magnification: 200×) (Olympus, Tokyo, Japan).
Tissue extraction
Diabetic Wistar rat tissue samples were homogenized for protein extraction in lysis buffer (20 mM Tris-base [pH 7.4], 2 mM EDTA, 50 mM b-mercaptoethanol and protease inhibitor tablets) at a concentration of 100 mg tissue/mL buffer. The homogenates were placed on ice for 10 min and then centrifuged at 13000 g for 40 min. The supernatants were collected separately and stored at -80°C for further analysis.
Cell culture
H9c2 cardiomyoblasts were purchased from American Type Culture Collection (ATCC) (Manassas, VA, USA) and were cultured in 100-mm dishes in Dulbecco's modified Eagle's medium (DMEM; Sigma, St. Louis, MO, USA) supplemented with 10% CCS in humidified air (5% CO 2 ) at 37°C. Cell culture medium was replaced 48 h after each sub-cultivation. About 3.5 mL PBS was used to wash each culture plate or vessel. H9c2 cells were transfected with b-catenin plasmid in a time-dependent and dose-dependent manner.
Transient transfection
Cells at 50% confluency were placed in a fresh culture medium containing serum 2 h before transfection. Then pCMV-b-catenin plasmid was transfected into the cells for 24 h with PureFection TM Nanotechnology-based Transfection Reagent (System Biosciences, Palo Alto, CA, USA) following the manufacturer protocol. In each experiment, efficiency of gene overexpression was measured by western blot analysis.
Neonatal rat primary cardiomyocyte culture
Primary cadiomyocytes were isolated from diabetic Wistar rats with Neonatal Rat/Mouse Cardiomyocyte Isolation System Kit (Cellutron Life Technology, Baltimore, MD, USA). Each 10-cm plate was coated with 4 mL SureCoat solution (Cellutron Life Technology, Baltimore, MD, USA) for 2 h in humidified air with 5% CO 2 at 37°C. Hearts of diabetic Wistar rats were isolated and incubated in digestion solution at 37°C. Each plate was coated with extra 5 mL SureCoat for 2 h in humidified air with 5% CO 2 at 37°C. Then all isolated cells were rested in non-coating dishes for 1 h, heart fibroblasts were seeded to the bottom of each plate www.cardiologyjournal.org and floating cells were primary cadiomyocytes, which were subsequently transferred to pre-coated plates. Finally, ventricular cardiomyocytes were cultured in DMEM containing 10% CCS. After 3-4 days, the cells were transfected with b-catenin plasmid in a dose-dependent treatment. 
Annexin V-FITC/PI staining
Western blot analysis
After the treatment cells were re-suspended in lysis buffer (50 mM Tris-base [pH 7.5], 0.5M NaCl, 1 mM b-mercaptoethanol, 1% NP-40, 1% glycerol and protease inhibitor tablets). Samples containing equal amounts of total protein (40 μg) were separated by 10% SDS-PAGE and then transferred onto polyvinylidene difluoride membranes (Millipore Corp., Billerica, MA, USA). Residual protein sites were blocked in 1 × Tween-20/Tris-buffered saline (1 × TBS) containing 5% skim milk. Then, the membranes were incubated with 1:1000 diluted primary antibody solutions in 1 × TBS buffer at 4°C for at least 1 overnight, depending affinity of each antibody. After the primary antibody solutions were recycled, blots were incubated with secondary antibody solutions 1 × TBS for 1 h.
Primary antibodies against b-actin, p-Akt, Bax, b-catenin, caspase-3, caspase-9, COL2A1, CTGF, cytochrome C, p-IGF1R, MMP2, MMP9, p-PI3K, p-Smad2/3, SP1, TIMP-1, TIMP-2, tPA and uPA were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Primary antibody against insulin-like growth factor-1 (IGF-1) was purchased from Abcam Plc. (Cambridge, United Kingdom). Secondary antibodies used in this study (anti-goat-HRP, anti-mouse-HRP and anti-rabbit-HRP) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
Assay of MMP2 and MMP9 activities by gelatin zymography
Activities of MMP2 and MMP9 were assessed by gelatin zymography. After neonatal cardiac fibroblasts were treated with the pCMVb-catenin plasmid in a dose-dependent manner, cell-conditioned media were collected. 20 μL of each sample was mixed with 5 μL loading dye (10% SDS, 0.5 M Tris--HCl [pH 6.8], 50% glycerol, 6.25 g bromophenol blue). The resulting mixtures were loaded to 8% SDS-PAGE gels containing 0.1% gelatin and run at 120 V for 2.5 h. Then, the gels were washed in a 2.5% Triton X-100 solution with shaking for 30 min and incubated in 50 mL reaction buffer (40 mM Tris-HCl [pH 8.0], 10 mM CaCl 2 , and 0.01% NaN 3 ) at 37°C overnight before staining with 0.25% Coomassie brilliant blue R-250 in 50% methanol and 10% acetic acid for 1 h. Quantitative analysis was performed after the gels were washed twice in a destaining solution (10% acetic acid, 20% methanol) for 30 min.
Statistical analysis
Experimental data in this study were given as the mean ± standard deviation. Two differences in the groups were compared and analyzed by Student t-test. To analyze differences in multiple groups one-way ANOVA was used and p < 0.05 was considered significant.
Results
Expression patterns of b-catenin in human infarct hearts and disease model hearts
Expression of b-catenin protein in human infarct hearts and in diseased animal model hearts were detected. Immunohistochemical staining patterns in myocardial infarction specimens from the cardiovascular tissue microarray were examined. The results showed that b-catenin staining increased and condensed around the increased interstitial space in the myocardial scar tissue (Fig. 1A) . In previous studies, the authors observed cardiac fibrosis and apoptosis in a diabetic animal model [19, 31] . In addition, b-catenin protein expression in diseased animal models was determined. b-catenin protein expression was elevated in diabetic rat hearts (Fig. 1B) . Therefore, b-catenin pathway was elevated when diabetes is present in Wistar rats and in humans.
Transfection of a dose-and time-dependent pCMV-beta-catenin plasmid induced cardiomyocyte apoptosis
To determine whether b-catenin is able to induce apoptosis in cardiomyocytes, flow cytometry and western blot analysis was conducted. When a pCMV-b-catenin plasmid was transfected in dosedependent and time-dependent manners, expression of apoptosis protein markers Bax, cytochrome c, caspase 3 and caspase 9 showed increased trends in neonatal rat cardiomyocytes and H9c2 cardiomyoblasts ( Fig. 2A, B) . Moreover, the percentage of apoptosis was enhanced in the cells transfected with 0.8 μg or 1.0 μg pCMV-b-catenin plasmid (Fig. 2C) . Caspase 3 protein expression was increased in H9c2 cardiomyoblasts transfected with 1.0 μg pCMV-b-catenin (Fig. 2D) . Therefore, b-catenin was capable of inducing apoptosis in cardiomyocytes in dose-and time-dependent manners.
Transfection of a dose-and time-dependent pCMV-beta-catenin plasmid reduces the expression of survival pathway protein markers
To determine whether b-catenin could reduce the survival of cardiomyocytes, western blot analysis was conducted. When pCMV-b-catenin plasmid was transfected into H9c2 and primary neonatal rat cardiomyocytes in dose-and time-dependent manners, expression of the survival pathway protein markers, IGF-1, p-IGF-1R, p-PI3K and p-Akt, were reduced (Fig. 3) . Therefore, b-catenin was able to downregulate IGF-1 pathway and survival in cardiomyocytes.
Transfection of a dose-and time-dependent pCMV-beta-catenin plasmid increased the expression of fibrosis protein markers
Finally, to determine the possibility of inducing fibrosis in cardiomyocytes, gelatin zymography and western blot analyses were conducted. Dosedependent and time-dependent transfection of pCMV-b-catenin plasmid upregulate the fibrosis protein markers, CTGF, MMP2, MMP9, p-Smad2/3, SP1, TIMP-1, TIMP-2, tPA and uPA, in both neonatal Wistar rat cardiomyocytes and H9c2 cardiomyoblasts (Fig. 4A, B) . It was found that the expression of the fibrosis protein markers SP1 and collagen II increased in neonatal cardiac fibroblasts alone (Fig. 4C) . Conditioned media from the transfection of dose-dependent pCMV-b-catenin plasmid into neonatal cardiac fibroblasts were collected and gelatin zymography was performed to measure activities of MMP2 and MMP9. The transfection of pCMV-b--catenin plasmid caused increased MMP2 and MMP9 activities (Fig. 4D) . Therefore, b-catenin overexpression can also induce fibrosis in cardiomyocytes. . Beta-catenin overexpression increased the expression of fibrosis protein markers and decreased the expression of TIMP-2 and TIMP-1; A. Neonatal rat cardiomyocytes were transfected with a dose-dependent pCMV b-catenin plasmid for 24 h; *p < 0.05 vs. control (increase); B. H9c2 cells were transfected with a 1 μg/mL pCMV b-catenin plasmid in a time-dependent manner. After transfection, expression of fibrosis protein markers were accessed by western blot analysis; *p < 0.05 vs. control (increase); **p < 0.01 vs. control (increase); ***p < 0.001 vs. control (increase); C, D. Neonatal cardiac fibroblasts were transfected with a dose-dependent pCMV b-catenin plasmid for 24 h. After transfection, the cells were collected and conditioned media were harvested. Western blot analysis and gelatin zymography were conducted to access effects of pCMV b-catenin plasmid on fibrosis; *p < 0.05 vs. control (increase).
Discussion
Certain humoral factors secreted by mechanically stressed cardiomyocytes activate a vast network of intra-and intercellular transduction signals that lead to cardiac dysfunctions [1] [2] [3] [4] [5] . Although such abnormalities can be compensated by cardiac hypertrophy, which is a fundamental process of adaptation to an increased workload due to hemodynamic overload [10] [11] [12] , loss of contractile tissue, cardiomyocyte apoptosis and mesenchymal fibrosis will eventually occur [13] . Beta-catenin signaling is activated during pathological cardiac remodeling induced by pressure overload in injured arteries and after myocardial infarction [14] . In addition, it was found to induce apoptosis in other mammalian cell types [16] [17] [18] , heart failure in rats [19] and cardiac fibrosis [20] . However, the role of b-catenin in apoptosis, fibrosis and survival in cardiomyocytes requires further study.
Factors that may trigger cardiomyocyte apoptosis include mechanical forces, oxidative stress and hypoxia as well as an unbalanced presence of growth factors and cytokines or neurotransmitters [33, 34] . Wnt/b-catenin signaling is known to be required for different aspects of cardiac and vascular development. Defective Wnt signaling can result in various cardiac and vascular abnormalities. Moreover, in other studies, it was indicated that Wnt signaling is involved in cardiovascular diseases coupled with ion channels and cardiac hypertrophy [35, 36] . In the present study, b-catenin expression was detected in human infarct hearts and in diseased animal model hearts. The results showed that b-catenin protein expression increased and condensed around the interstitial space in the myocardial scar tissue. In addition, expression levels of the transcription factor b-catenin was found to be increased in diabetic rat hearts. Thus, b-catenin might play a crucial role in apoptosis induction in cardiomyocytes. Expression of apoptosis markers (Bax, cytochrome c, caspase 3 and caspase 9) was upregulated after transfection of pCMV-b-catenin plasmid in neonatal rat cardiomyocytes and H9c2 cardiomyoblasts. Moreover, the apoptosis level was found to be elevated by transfection with pCMV-b-catenin plasmid.
In a recent review, it was reported that transforming growth factor beta 3 (TGFb3) could induce fibrosis through Smad and/or b-catenin signaling and addressed the role of apoptosis in fibrosis [37] . Arrhythmogenic right ventricular dysplasia/ cardiomyopathy (ARVD/C) is an inherited cardiac arrhythmia originating in the right ventricle and results in heart failure and sudden cardiac death. Development of ARVD/C type 1 has been attributed to differential expression of TGFb3. TGFb3 www.cardiologyjournal.org overexpression could have an activating role in Wnt/b-catenin pathway. In human renal proximal tubular cells, TGFBR2 was shown to dissociate from adherent junctions upon TGFb1 activation [38] . TGFb3 is also known to bind to the same receptor, possibly eliciting a similar process in the heart. Incubation with TGFb1 yielded increased levels of b-catenin and dissociation of b-catenin from adherent junction complexes was observed previously [39] . In addition, cytoplasmic b-catenin was stabilized by TGFb activity, thereby promoting Wnt/b-catenin signaling [38, 39] . Transfection with pCMV-b-catenin plasmid increased fibrosis markers (uPA, tPA, MMP2, MMP9) in neonatal rat cardiomyocytes and in H9c2 cardiomyoblasts. In addition, expression of fibrosis markers SP1 and collagen II increased in neonatal cardiac fibroblasts alone. Taken together, these demonstrated that Wnt/b-catenin pathway could be necessary for TGFb-induced fibrosis in cardiomyocytes [23, 24] .
Transforming growth factor b signaling has also been implicated in both cell growth and apoptosis, depending on the concentration of the cytokine and on the signaling context. Myocardial cells of patients suffering from ARVD/C were shown to express and overexpress proapoptotic caspase 3 and Bax, respectively [40, 41] . In different studies, hypoxia was shown to induce TGFb activity [42] [43] [44] . In addition, activities of b-catenin and TGFb were shown to be co-related [45] [46] [47] .
Conclusions
In conclusion, Wnt/b-catenin signaling cascade is capable of damaging cardiomyocytes and this study will provide a clear picture in treatment of cardiovascular disease. Strategies of targeting b-catenin expression in cardiomyocytes assists in preventing heart cells from myocardial infarctioninduced apoptosis, fibrosis and reduced survival.
